gabexate has been researched along with Polyarthritis in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, K | 1 |
| Ohzawa, N | 1 |
| Nakayama, K | 1 |
| Nagao, Y | 1 |
| Miyata, H | 1 |
| Inaba, H | 1 |
| Kosuzume, H | 1 |
| Gohda, K | 1 |
| Fukutake, K | 1 |
1 other study available for gabexate and Polyarthritis
| Article | Year |
|---|---|
[Effects of ulinastatin on experimental arthritis].
Topics: Animals; Antibody-Producing Cells; Aprotinin; Arthritis; Arthritis, Experimental; Carrageenan; Carti | 1988 |